First Horizon Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$630K Sell
9,129
-286
-3% -$18.8K 0.02% 309
2025
Q1
$638K Buy
9,415
+2,513
+36% +$150K 0.02% 296
2024
Q4
$310K Sell
6,902
-2,022
-23% -$113K 0.01% 435
2024
Q3
$561K Sell
8,924
-815
-8% -$47.5K 0.02% 329
2024
Q2
$575K Sell
9,739
-1,680
-15% -$105K 0.02% 311
2024
Q1
$911K Sell
11,419
-3
-0% -$229 0.03% 262
2023
Q4
$902K Sell
11,422
-140
-1% -$9.96K 0.03% 265
2023
Q3
$807K Buy
11,562
+44
+0.4% +$3.12K 0.03% 267
2023
Q2
$796K Sell
11,518
-367
-3% -$26.1K 0.03% 278
2023
Q1
$883K Sell
11,885
-50
-0.4% -$4.19K 0.03% 272
2022
Q4
$1.11M Sell
11,935
-59
-0.5% -$5.69K 0.04% 248
2022
Q3
$1.14M Sell
11,994
-1,122
-9% -$111K 0.05% 239
2022
Q2
$1.21M Buy
13,116
+3,116
+31% +$304K 0.04% 243
2022
Q1
$1.01M Sell
10,000
-4,918
-33% -$517K 0.06% 224
2021
Q4
$1.54M Buy
14,918
+2,129
+17% +$197K 0.05% 245
2021
Q3
$1.08M Buy
12,789
+891
+7% +$74.6K 0.04% 269
2021
Q2
$992K Buy
11,898
+1,004
+9% +$82.2K 0.05% 193
2021
Q1
$820K Buy
10,894
+695
+7% +$50.6K 0.05% 203
2020
Q4
$696K Buy
10,199
+473
+5% +$30.8K 0.05% 195
2020
Q3
$566K Buy
9,726
+2,310
+31% +$144K 0.04% 197
2020
Q2
$480K Sell
7,416
-1,150
-13% -$72.4K 0.04% 209
2020
Q1
$507K Sell
8,566
-68
-0.8% -$4.54K 0.05% 196
2019
Q4
$641K Buy
8,634
+105
+1% +$7.37K 0.05% 195
2019
Q3
$537K Sell
8,529
-3,516
-29% -$208K 0.04% 206
2019
Q2
$655K Sell
12,045
-67
-0.6% -$3.61K 0.05% 199
2019
Q1
$652K Sell
12,112
-510
-4% -$31.5K 0.05% 200
2018
Q4
$825K Sell
12,622
-6,522
-34% -$487K 0.07% 184
2018
Q3
$1.51M Buy
19,144
+3,791
+25% +$271K 0.12% 154
2018
Q2
$986K Buy
15,353
+8,106
+112% +$534K 0.08% 178
2018
Q1
$452K Sell
7,247
-295
-4% -$21.2K 0.04% 213
2017
Q4
$555K Buy
7,542
+285
+4% +$20.7K 0.05% 198
2017
Q3
$589K Buy
7,257
+209
+3% +$16.5K 0.06% 192
2017
Q2
$564K Sell
7,048
-461
-6% -$36.4K 0.06% 195
2017
Q1
$595K Sell
7,509
-2,108
-22% -$168K 0.07% 193
2016
Q4
$851K Hold
9,617
0.11% 169
2016
Q3
$851K Sell
9,617
-49,472
-84% -$4.67M 0.11% 171
2016
Q2
$5.66M Sell
59,089
-5,757
-9% -$574K 0.77% 34
2016
Q1
$6.74M Buy
64,846
+7,127
+12% +$693K 0.75% 39
2015
Q4
$5.64M Buy
57,719
+985
+2% +$96.5K 1% 22
2015
Q3
$5.47M Sell
56,734
-2,684
-5% -$282K 0.84% 32
2015
Q2
$6.23M Sell
59,418
-2,925
-5% -$299K 0.9% 24
2015
Q1
$6.44M Sell
62,343
-1,368
-2% -$138K 0.93% 23
2014
Q4
$6.14M Sell
63,711
-420
-0.7% -$37K 0.94% 22
2014
Q3
$5.1M Sell
64,131
-287
-0.4% -$22.6K 0.8% 25
2014
Q2
$4.87M Buy
64,418
+2,249
+4% +$170K 0.7% 28
2014
Q1
$4.65M Sell
62,169
-2,423
-4% -$171K 0.65% 26
2013
Q4
$4.44M Buy
64,592
+448
+0.7% +$28.8K 0.66% 22
2013
Q3
$3.64M Buy
64,144
+59,683
+1,338% +$3.56M 0.59% 30
2013
Q2
$255K Buy
+4,461
New +$258K 0.13% 63

Other funds holding CVS

First Horizon Advisors's CVS Position: Q2 2025 in Review

First Horizon Advisors reduced its CVS Health (CVS) stake by 3% in Q2 2025, selling an estimated $18.8K and leaving 9,129 shares worth $630K. The position accounts for 0.02% of the portfolio, ranked #309.

First Horizon Advisors first reported a position in CVS in Q2 2013 and has held it in 49 quarters since. The position peaked at $6.74M in Q1 2016. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • First Horizon Advisors held 9,129 shares of CVS Health worth $630K as of Q2 2025.
  • First Horizon Advisors sold 286 CVS Health shares in Q2 2025, an estimated $18.8K.
  • CVS Health made up 0.02% of First Horizon Advisors's portfolio in Q2 2025, its #309 holding.
  • First Horizon Advisors first reported a position in CVS Health in Q2 2013 and has held it in 49 quarters since.
  • First Horizon Advisors's CVS Health position peaked at $6.74M in Q1 2016.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.